{"id":15403,"date":"2022-10-10T10:51:04","date_gmt":"2022-10-10T08:51:04","guid":{"rendered":"http:\/\/osloeconomics.no\/?p=15403"},"modified":"2025-12-11T14:11:49","modified_gmt":"2025-12-11T13:11:49","slug":"oslo-economics-have-presented-their-ongoing-study-on-myasthenia-gravis-in-the-u-s-and-denmark","status":"publish","type":"post","link":"https:\/\/osloeconomics.no\/en\/oslo-economics-have-presented-their-ongoing-study-on-myasthenia-gravis-in-the-u-s-and-denmark\/","title":{"rendered":"Oslo Economics have presented their ongoing study on myasthenia gravis in the U.S. and Denmark\u00a0"},"content":{"rendered":"\n<p>Oslo Economics, UCB Pharma and the University of Bergen are currently collaborating on a research project about the societal costs of myasthenia in Norway. Christoffer Bugge and Ingrid Engebretsen from Oslo Economics have presented preliminary results from the research project on two different conferences. On September 21<sup>st<\/sup> ., Christoffer Bugge and Ingrid Engebretsen presented the study at the yearly conference held by the American Association of Neuromuscular &amp; Electrodiagnostic Medicine (AANEM) in Nashville, Tennessee. On October 1<sup>st <\/sup>, Ingrid presented the study at the \u201cLiving with Myasthenia gravis\u201d-conference in Denmark. The study is financed by UCB Pharma.\u00a0<\/p>\n\n\n\n<div class=\"wp-block-group is-content-justification-center is-nowrap is-layout-flex wp-container-core-group-is-layout-94bc23d7 wp-block-group-is-layout-flex\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100%\">\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/osloeconomics.no\/wp-content\/uploads\/2022\/10\/bugge.jpg\" alt=\"\" class=\"wp-image-15387\" width=\"333\" height=\"444\" srcset=\"https:\/\/osloeconomics.no\/wp-content\/uploads\/2022\/10\/bugge.jpg 480w, https:\/\/osloeconomics.no\/wp-content\/uploads\/2022\/10\/bugge-225x300.jpg 225w\" sizes=\"auto, (max-width: 333px) 100vw, 333px\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/osloeconomics.no\/wp-content\/uploads\/2022\/10\/Bilde1.jpg\" alt=\"\" class=\"wp-image-15390\" width=\"333\" height=\"445\" srcset=\"https:\/\/osloeconomics.no\/wp-content\/uploads\/2022\/10\/Bilde1.jpg 573w, https:\/\/osloeconomics.no\/wp-content\/uploads\/2022\/10\/Bilde1-225x300.jpg 225w\" sizes=\"auto, (max-width: 333px) 100vw, 333px\" \/><\/figure>\n<\/div><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Oslo Economics, UCB Pharma and the University of Bergen are currently collaborating on a research project about the societal costs of myasthenia in Norway. <\/p>\n","protected":false},"author":4,"featured_media":15128,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[88],"tags":[],"class_list":["post-15403","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-and-life-science"],"acf":[],"_links":{"self":[{"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/posts\/15403","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/comments?post=15403"}],"version-history":[{"count":2,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/posts\/15403\/revisions"}],"predecessor-version":[{"id":15405,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/posts\/15403\/revisions\/15405"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/media\/15128"}],"wp:attachment":[{"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/media?parent=15403"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/categories?post=15403"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/tags?post=15403"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}